Vivek Narayanadas Sells 238 Shares of Oklo (NYSE:OKLO) Stock
📉 Oklo reported a loss of $0.28 per share in the latest quarter, missing analyst expectations of a $0.16 loss.
💰 The company achieved significant revenue growth with $1.21 million reported, up 11,900% year-over-year from the prior period.
🏦 Institutional ownership stands at 85.03%, with several wealth management firms adding new stakes in Q3 and Q4.
📉 General Counsel Vivek Narayanadas sold 238 shares for $10,010 to cover tax withholding obligations under a pre-arranged plan.
🎯 Analyst price targets vary widely, ranging from a high of $110 by Wedbush to a low of $55 by UBS Group.
⚖️ The stock carries a 'Moderate Buy' average rating with an average target price of $83.26 according to MarketBeat data.
Bullish Signals
- Oklo reported revenue of $1.21 million for the quarter, representing a staggering 11,900% year-over-year increase.
- Institutional ownership remains robust at 85.03%, with multiple wealth management firms establishing or increasing positions in recent quarters.
Risk Factors
- The company posted an adjusted loss of $0.28 per share, missing analyst consensus estimates of a smaller loss of $0.16.
- Major institutional analysts including Citigroup and UBS have lowered their price targets to neutral levels around $57.50 and $55.00 respectively.
Full Analysis
Oklo Inc., a California-based energy technology firm specializing in advanced nuclear microreactors, reported its quarterly earnings on August 7th. The company delivered revenue of $1.21 million, representing a massive 11,900% year-over-year increase compared to the prior period's negligible revenue. However, the firm posted an adjusted loss of $0.28 per share, which missed analyst consensus estimates of a smaller loss of $0.16 per share.
Following the earnings release, institutional investor activity has been mixed but notable. Several wealth management firms, including Costello Asset Management, Gilpin Wealth Management, and SHP Wealth Management, established or increased their positions in the stock during the third and fourth quarters. Hedge funds and other institutional investors collectively own 85.03% of the outstanding shares.
Analyst sentiment remains divided regarding the company's valuation and future prospects. While Wedbush maintains an 'outperform' rating with a $110 price target and HC Wainwright reaffirms a 'buy' at $90, other major institutions like Citigroup and UBS have lowered their price targets to neutral levels around $57.50 and $55.00 respectively, reflecting uncertainty about the path to profitability for this SMR developer.
